NEW WINDSOR, N.Y. (April 20, 2015) – MedTech Association, a membership-based, bioscience and medical technology (Bio/Med) trade association for New York State (NYS), and NY BioHud Valley, a cluster development initiative formed by the Hudson Valley Economic Development Corporation (HVEDC) to establish the Hudson Valley corridor as a global leader in the life sciences, pharmaceutical and medical device industries, are proud to announce a new strategic partnership to further the development of the Bio/Med industry in NYS.
The organizations will work together to advance the Bio/Med industry in NYS, initially collaborating on coordinating interests for state and federal priorities from an advocacy perspective, cross-promoting efforts to expand awareness of the industry and involving each other in future programming, specifically in the Capital Region and Downstate. As the relationship matures, additional areas of collaboration may emerge.
NY BioHud Valley is dedicated to recognizing and promoting the growing cluster of biotech, pharmaceutical and life science companies located in the Hudson Valley. An integral part of the NYS Bio/Med economy, which MedTech works to connect through collaboration, education and advocacy, NY’s Downstate Region (including the NYC, Long Island, and the Mid-Hudson Regions) employs nearly 46,000 in direct bioscience jobs, which through indirect and induced effects, contribute about 128,000 total jobs across the state’s economy, according to MedTech’s industry report, Bio/Med Breakthroughs: 2014 Bio/Med Industry Report.
“Building a stronger life sciences cluster in the Hudson Valley requires tearing down the artificial borders separating regions in order to form compelling alliances with like-minded organizations seeking to accelerate NYS’s growth in this critical sector,” stated Laurence Gottlieb, president and CEO of HVEDC and founder of NY BioHud Valley. “Like NY BioHud Valley, MedTech has emerged as a powerful advocate for NY-based biotech and pharmaceutical companies, so forming this partnership between the two groups will create a dynamic, statewide voice for the industry.”
The most prevalent industry subsector in NY is drugs and pharmaceuticals, with a concentration that is eight percent greater than that seen nationally. In Upstate NY specifically, the medical device sector is 26% more concentrated than the national average. Across NY, the more than 75,000 bioscience workers earned $5.7 billion in total wages and salaries in 2012, which translates into an average annual wage of $76,112. Bio/Med in NY has a total compensation impact of $16.8 billion (includes direct, indirect and induced impacts), producing $62.6 billion toward Gross State Product (includes direct, indirect and induced impacts).
“We are excited to formally partner with NY BioHud Valley,” said Jessica Crawford, MedTech Association president. “MedTech was initially formed as a resource serving the Upstate NY Bio/Med industry. Working with NY BioHud Valley further solidifies our statewide mission and ability to advance the industry, bridging the gap between upstate and downstate. Together we will leverage our collective strengths in biotech and medical technology to ensure NY – which is among the top tier of states in the size of its bioscience industry and the scale and reach of its bioscience research – continues as a center for Bio/Med activity.”
MedTech connects New York State’s Bio/Med industry through collaboration, education and advocacy. We are an active association of over 100 pharmaceutical, biotech and medical technology companies, their suppliers and service providers and research universities. For more than 10 years we have boosted the success and growth of our members. For more information, visit www.medtech.org. Like MedTech on Facebook and follow MedTech on Twitter.
ABOUT NY BIOHUD VALLEY
The Hudson Valley employs over 9,600 biomedical professional and is home to an exceptional mix of both well-established and new biotech/pharmaceutical companies. With Pfizer, Regeneron Pharmaceuticals, Acorda Therapeutics and 80+ other pharmaceutical, biotechnology, medical device and digital health companies located in the region, the Hudson Valley offers abundant collaborative research opportunities and a strong supplier network. More than 60% of the nation’s pharmaceutical industry is centered in metro New York, where biotech firms are flourishing and new digital health firms are cropping up every day.
The goal of the NY BioHud Valley initiative is to aggressively market and brand this fast-growing cluster – solidifying the Hudson Valley’s position as a global epicenter of health technology and innovation. In addition, we foster a pro-business environment designed to reduce legislative burdens, foster collaboration among our life sciences companies and educational institutions, and assist companies with access to venture capital.
ABOUT THE HUDSON VALLEY ECONOMIC DEVELOPMENT CORPORATION (HVEDC)
Hudson Valley Economic Development Corporation (HVEDC) is the leading economic development agency for the seven-county region of Westchester, Putnam, Dutchess, Rockland, Orange, Ulster and Sullivan counties. The public-private partnership markets the region as a prime business location to corporate executives, site selection consultants and real estate brokers. HVEDC founded several of New York’s most active industry cluster development initiatives including NY BioHud Valley, Hudson Valley 3D Printing (HV3D), Hudson Valley EDs & MEDs and the Hudson Valley Food & Beverage Alliance.